美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NED Davis Research 360 Dynamic Allocation Etf

19.48

0.0000

成交量：3.00

成交額：58.53

市值：253.30萬

市盈率：- -

高：19.48

開：19.48

低：19.48

收：19.48

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

2024藥企出海：做難而正確的事

国际金融报

近9000億美元軍費支出拜登簽署2025財年國防授權法案

美媒：美參議院推進《國防授權法案》，為最終通過年度國防政策法案做準備

美全面禁止從科技到大蒜等中國商品法案充斥着同中國對抗

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NDAA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NDAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NDAA\",,,,,undefined,":{"symbol":"NDAA","market":"US","secType":"STK","nameCN":"NED Davis Research 360 Dynamic Allocation Etf","latestPrice":19.4844,"timestamp":1747425600000,"preClose":19.4844,"halted":0,"volume":3,"delay":0,"floatShares":130000,"shares":130000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"05-16 16:00:00 EDT","open":19.4844,"high":19.4844,"low":19.4844,"amount":58.53,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":19.4844,"sharesOutstanding":130000,"nav":19.48,"aum":2532400,"bidAskSpread":0,"volumeRatio":0.003446690978475932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NDAA\",,,,,undefined,":{"symbol":"NDAA","floatShares":130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.003446690978475932,"shares":130000,"dividePrice":0,"high":19.4844,"amplitude":0,"preClose":19.4844,"low":19.4844,"week52Low":17.52,"pbRate":"--","week52High":20.41,"institutionHeld":0,"latestPrice":19.4844,"eps":0,"divideRate":0,"volume":3,"delay":0,"ttmEps":0,"open":19.4844,"prevYearClose":19.6666,"prevWeekClose":18.5686,"prevMonthClose":18.5686,"prevQuarterClose":19.401,"fiveDayClose":18.5686,"twentyDayClose":18.3266,"sixtyDayClose":19.99},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NDAA\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NDAA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495054976","title":"2024藥企出海：做難而正確的事","url":"https://stock-news.laohu8.com/highlight/detail?id=2495054976","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495054976?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 20:41","pubTimestamp":1735562466,"startTime":"0","endTime":"0","summary":"2024年，出海依然是生物医药产业的关键词。ADC、双抗药物合作交易火爆，出海数量再创新高；交易金额上限不断突破，多家药企凭借出海扭亏为盈。海外市场为生物医药产业带来了新的增量和发展方向，但走好出海之路绝非易事。近年来，创新药海外合作数量上升的同时，也有部分合作半路终止。此外，还有企业受地缘政治等因素影响，割舍或是调整海外业务。不过，好在各方都没有放弃，而是积极探索出新的道路。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412303282962268.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282962268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PML","ADC","GSK.UK","02162","LU1829250122.USD","NDAA","BK4532","BMS","BK1574","BK1161","BK4231","GSK","09939","BK1583","BK4585","BK1587","BK4588","BK4007","BK1515","BK4080"],"gpt_icon":0},{"id":"2493727494","title":"近9000億美元軍費支出 拜登簽署2025財年國防授權法案","url":"https://stock-news.laohu8.com/highlight/detail?id=2493727494","media":"环球时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493727494?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 13:51","pubTimestamp":1735019460,"startTime":"0","endTime":"0","summary":"当地时间23日，美国总统拜登签署2025财年国防授权法案，将美国军费支出提升至约8950亿美元，较上一财年增长1%。2025财年国防授权法案将提升现役军人工资，增加在亚太的军事支出，并授权美军与以色列军队拓展联合军事演习等。桑德斯认为，美国的国防体系已成为少数大型国防承包商牟利的工具，而不是服务于国家需要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-24/doc-ineapwes8469507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"gpt_icon":0},{"id":"2492860614","title":"美媒：美參議院推進《國防授權法案》，為最終通過年度國防政策法案做準備","url":"https://stock-news.laohu8.com/highlight/detail?id=2492860614","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492860614?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 11:47","pubTimestamp":1734407273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["NDAA"],"gpt_icon":0},{"id":"2490071840","title":"美全面禁止從科技到大蒜等中國商品 法案充斥着同中國對抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2490071840","media":"映象网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490071840?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 11:19","pubTimestamp":1733973540,"startTime":"0","endTime":"0","summary":"从激光导航技术到大蒜，美国国会众议院已经通过了一项包含禁止诸多中国进口商品的法案，并极有可能在今年年底成为正式法律。报道指出，“国防授权法案”为美国国防部设定了最高预算并指导政策方向，可谓是一项“必须通过”的法案，因为该法案的颁布是军人按时领取薪资和福利的必要条件。而与往年一样，2025财年的“国防授权法案”充斥着“同中国竞争和对抗”的相关内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-12/doc-inczekkt3179903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NDAA\",params:#limit:5,,,undefined,":[{"date":"2024-12-26","symbol":"NDAA","amount":0.16273,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-26","defaultRemindTime":1735223400000,"name":"NED Davis Research 360 Dynamic Allocation Etf","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-26","currency":"USD","dateTimestamp":1735189200000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NDAA\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-26","recordDate":"2024-12-26","paymentDate":"2024-12-30","value":0.16273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NDAA\",market:\"US\",delay:false,,,undefined,":{}}}